Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ·Healthcare·Biotechnology
$5.04
-2.33%
Mkt Cap $311.50M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (6 analysts)
$14.25
Range $7.50 – $21.00
Implied Upside
+182.7%
Consensus $14.25 vs current $5.04
NASDAQ·Healthcare·Biotechnology
$5.04
-2.33%
Mkt Cap $311.50M
Buy
2
Hold
0
Sell
0
Price Target (6 analysts)
$14.25
Range $7.50 – $21.00
+182.7%
Consensus $14.25 vs current $5.04